BOSTON--(BUSINESS WIRE)--Beaconcure, a leader in AI-enabled clinical data validation and automation, has launched its new Verify capability to automate validation of statistical analysis outputs against Analysis Data Model (ADaM) datasets. Verify is a secure online workspace that allows clinical research teams to collaborate on clinical study analysis validation and workflows, and it has been used to validate hundreds of clinical studies to date.

BOSTON-（BUSINESS WIRE）-Beaconcure是启用AI的临床数据验证和自动化领域的领导者，推出了新的验证功能，可根据分析数据模型（ADaM）数据集自动验证统计分析输出。Verify是一个安全的在线工作空间，允许临床研究团队在临床研究分析验证和工作流程方面进行合作，迄今为止它已被用于验证数百项临床研究。

ADaM standards play a key role in the clinical research process, by providing a structured and consistent framework for organizing and analyzing data, making it easier to generate accurate findings..

ADaM标准通过提供组织和分析数据的结构化且一致的框架，使其更容易生成准确的发现，在临床研究过程中起着关键作用。。

Validating outputs against ADaM allows biostatisticians and clinical programmers to confirm that analyses accurately reflect the intended version of core data. This validation is generally performed manually, using double programming or visual review. By using the new automated Verify processes to validate outputs against ADaM datasets, programmers can quickly identify and remediate discrepancies that might not have been found through traditional methods.

针对ADaM验证输出允许生物统计学家和临床程序员确认分析准确反映核心数据的预期版本。该验证通常使用双重编程或视觉检查手动执行。通过使用新的自动验证过程来验证针对ADaM数据集的输出，程序员可以快速识别和修复传统方法可能找不到的差异。

Irving Dark, biometrics expert and Beaconcure Strategic Advisory Board member, stated that “The ability to use AI to validate outputs against ADaM provides biopharmaceutical companies an enhanced layer of reliability and accuracy in clinical analysis. The addition of this Verify feature further sets Beaconcure apart as an innovator in addressing the industry’s current and future challenges.”.

Irving Dark，生物识别专家和Beaconsene战略咨询委员会成员表示，“使用AI验证ADaM输出的能力为生物制药公司提供了临床分析中更高的可靠性和准确性。此验证功能的添加进一步使之成为可能。作为解决行业当前和未来挑战的创新者。”.

Using Verify as a collaborative workspace allows global users to work together to identify, assign, and resolve issues, with an automatically generated audit trail. The new capability automates data extraction and calculations across multiple ADaM datasets and correlates values to the corresponding outputs.

使用验证作为协作工作区允许全局用户通过自动生成的审计跟踪共同识别，分配和解决问题。新功能可自动执行多个ADaM数据集的数据提取和计算，并将值与相应的输出相关联。

Automated validation workflows can help sponsors increase the volume of studies analyzed and improve the accuracy and traceability of statistical analysis outputs. Beaconcure COO and co-founder Ilan Carmeli comments on the expanded Verify validation capabilities, highlighting the significance to pharmaceutical innovation: “Automated validation of outputs against ADaM datasets enables statistical programmers and biostatisticians to focus on higher-value activities, such as new data visualizations and summaries, changing requirements, and complex data analyses.

自动化验证工作流程可以帮助申办者增加分析研究的数量，并提高统计分析输出的准确性和可追溯性。Beacongure首席运营官和共同创始人Ilan Carmeli对扩展的验证验证功能提出了评论，强调药物创新的重要性：“针对ADaM数据集自动验证输出使统计程序员和生物统计学家能够专注于更高价值的活动，例如新的数据可视化和摘要，不断变化的需求以及复杂的数据分析。

This is also an important step towards our vision of replacing double programming.”.

这也是我们取代双重编程愿景的重要一步“。

About Beaconcure, Inc.

关于Beaconcure，Inc。

Beaconcure supports biopharmaceutical companies and CROs with an automated clinical trial data processing technology solution called ‘Verify’. Designed in partnership with trusted large pharmaceutical companies and used in an increasing number of approved products, ‘Verify’ shortens time to submission, reduces error rates, and reduces costs over current processes and solutions.

Beaconcure通过称为“Verify”的自动化临床试验数据处理技术解决方案为生物制药公司和CRO提供支持。与受信任的大型制药公司合作设计，并用于越来越多的已批准产品，“验证”缩短了提交时间，降低了错误率，并降低了当前流程和解决方案的成本。

For more information, visit www.beaconcure.com..

欲了解更多信息，请访问www.beaconcure.com。。